Status:
Recruiting
Disease Site:
Lung
Diagnosis:
- Metastatic Non-Small Cell Lung Cancer
- Extensive-Stage Small-Cell Lung Cancer
Phase:
Official Title:
A Multicenter, Low-Interventional Study to Evaluate the Feasibility of a Prospective Clinicogenomic Program
NCT ID:
NCT#04180176
Link to Full Details:
Investigators:
- Byron Jennings, M.D.
Description:
The main purpose of this study is to evaluate the feasibility of a scalable, prospective research program for participants with metastatic non-small cell lung cancer (mNSCLC) or extensive-stage small-cell lung cancer (ES-SCLC) planning to start standard-of-care (SOC) systemic anti-cancer treatment. The study will also examine ctDNA status over the course of treatment as a predictor of response to therapy.
Eligibility:
Male and Female – 18 years and older
Inclusion Criteria:
- Documented diagnosis of mNSCLC or ES-SCLC
- Planned initiation of SOC systemic anti-cancer treatment
Exclusion Criteria:
- Participation in an interventional trial at the time of signing informed consent
Other Info:
Participants will have blood drawn at enrollment, the first tumor assessment, and at disease progression or end of therapy.